Harmony Biosciences director granted 21,872 options

Harmony Biosciences Holdings, Inc. director Philip Ron M reported a compensation-related grant of stock options.

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. director Philip Ron M reported a compensation-related grant of stock options. He was awarded 21,872 stock options for Common Stock with an exercise price of $30.76 per share, all held directly after the grant.

The options expire on May 14, 2036 and will vest in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant, subject to his continued service. This filing reflects an acquisition of derivative securities, not an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 21,872 shares

Grant/Award 1 txn

Insider Philip Ron M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	21,872	$0.00	$0.00

Holdings After Transaction: Stock Option — 21,872 contracts (Direct)

Footnotes (1)

1. F1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Key Figures

Options granted: 21,872 options Exercise price: $30.76 per share Expiration date: May 14, 2036 +2 more

5 metrics

Options granted 21,872 options Stock option grant to director on May 14, 2026

Exercise price $30.76 per share Conversion or exercise price of granted options

Expiration date May 14, 2036 Option expiration for director grant

Vesting date trigger May 14, 2027 Latest full vesting date, or earlier next annual meeting

Post-transaction options held 21,872 options Total derivative securities held directly after grant

Key Terms

Stock Option, grant/award acquisition, Common Stock, exercise price, +1 more

5 terms

Stock Option financial

"The stock option shall vest in full on the earlier to occur of"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

Common Stock financial

"underlying_security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

exercise price financial

"conversion_or_exercise_price": "30.7600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The stock option shall vest in full on the earlier to occur of"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Philip Ron M report in this Harmony Biosciences (HRMY) Form 4?

He reported a grant of 21,872 stock options for Harmony Biosciences Common Stock. These derivative securities were awarded as compensation rather than bought on the open market, and are held directly following the transaction according to the filing details.

What are the key terms of the 21,872 Harmony Biosciences stock options granted to Philip Ron M?

The grant covers 21,872 stock options with an exercise price of $30.76 per share. The options relate to Harmony Biosciences Common Stock and are scheduled to expire on May 14, 2036, giving a long-dated right to purchase shares at that price.

When do Philip Ron M’s Harmony Biosciences (HRMY) stock options vest?

The options vest in full on the earlier of May 14, 2027, or the date of the next annual meeting following the grant. Vesting is contingent on his continued service through the applicable vesting date, as described in the footnote.

Did Philip Ron M buy or sell Harmony Biosciences shares on the open market in this Form 4?

No, the Form 4 reports a grant or award acquisition of stock options, not an open-market trade. The transaction is coded as “A,” indicating a grant of derivative securities as compensation rather than a discretionary market purchase or sale.

How many Harmony Biosciences derivative securities does Philip Ron M hold after this grant?

After the reported transaction, he holds 21,872 stock options directly, matching the number granted in this filing. The derivativeSummary shows no additional option positions, so this grant represents the full derivative position visible in the reported data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Philip Ron M

(Last) (First) (Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

630 W GERMANTOWN PIKE, SUITE 215

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$30.76	05/14/2026		A		21,872		(1)	05/14/2036	Common Stock	21,872	$0	21,872	D

Explanation of Responses:

1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)